Key Market Indicator:
Ad-hoc news is mandatory information from listed companies that must be made available to investors. Depending on the occasion and content of the news, it can have an impact on the share price. The newsfeed covers a wide range of topics relevant to investor relations and is recommended as an important source of information before making an investment decision.
NL0012768675
Thu, 20.10.2022       IGEA Pharma N.V.
NL0012768675

  IGEA DISCLOSES ITS 2021 ANNUAL REPORT Hoofddorp, the Netherlands, 20 October 2022. IGEA Pharma N.V. (SIX: IGPH) today announced the disclosure of its 2021 Annual Report. Highlights The Group generated marginal revenues of Keur 103,3 for the year ended 31 December 2021 (previous year: Keur 123,7) due to the ongoing efforts to establish market  [ … ]
Technical analysis
To the publication
Fri, 30.09.2022       IGEA Pharma N.V.
NL0012768675

  IGEA to get SIX approval to the semi-annual 2022  report disclosure   Hoofddorp, the Netherlands, 30 September 2022. IGEA Pharma N.V. (SIX: IGPH) today announced the grant of a temporary exemption from its disclosure obligations with respect to the half year 2022  report.   In accordance with our statutory auditors, considering that we will  [ … ]
Technical analysis
To the publication
Fri, 30.09.2022       IGEA Pharma N.V.
NL0012768675

  IGEA to get SIX approval to the semi-annual 2022  report disclosure   Hoofddorp, the Netherlands, 30 September 2022. IGEA Pharma N.V. (SIX: IGPH) today announced the grant of a temporary exemption from its disclosure obligations with respect to the half year 2022  report.   In accordance with our statutory auditors, considering that we will  [ … ]
Technical analysis
To the publication
Tue, 09.08.2022       IGEA Pharma N.V.
NL0012768675

  IGEA to get SIX further approval to the 2021 annual report disclosure   Hoofddorp, the Netherlands, 09 August 2022. IGEA Pharma N.V. (SIX: IGPH) today announced the grant of a temporary exemption from its disclosure obligations with respect to the 2021 annual report.   On request of the statutory auditors, even if the 2021 Annual Report is c [ … ]
Technical analysis
To the publication
Tue, 09.08.2022       IGEA Pharma N.V.
NL0012768675

  IGEA to get SIX further approval to the 2021 annual report disclosure   Hoofddorp, the Netherlands, 09 August 2022. IGEA Pharma N.V. (SIX: IGPH) today announced the grant of a temporary exemption from its disclosure obligations with respect to the 2021 annual report.   On request of the statutory auditors, even if the 2021 Annual Report is c [ … ]
Technical analysis
To the publication
Fri, 15.07.2022       IGEA Pharma N.V.
NL0012768675

  IGEA to get SIX further approval to the 2021 annual report disclosure   Hoofddorp, the Netherlands, 15 July 2022. IGEA Pharma N.V. (SIX: IGPH) today announced the grant of a temporary exemption from its disclosure obligations with respect to the 2021 annual report.   On request of the statutory auditors, in order to complete the analysis of  [ … ]
Technical analysis
To the publication
Fri, 15.07.2022       IGEA Pharma N.V.
NL0012768675

  IGEA to get SIX further approval to the 2021 annual report disclosure   Hoofddorp, the Netherlands, 15 July 2022. IGEA Pharma N.V. (SIX: IGPH) today announced the grant of a temporary exemption from its disclosure obligations with respect to the 2021 annual report.   On request of the statutory auditors, in order to complete the analysis of  [ … ]
Technical analysis
To the publication
Wed, 13.07.2022       IGEA Pharma N.V.
NL0012768675

IGEA PHARMA HAS ANNOUNCED THAT LMH - AN INDUSTRIAL HOLDING COMPANY - HAS COMPLETED THE DUE DILIGENCE PROCESS FOR A EURO 6.000.000 COMMITTMENT TO FUND THE SWISS CBD EXTRACTION FACILITY .   Hoofddorp, the Netherlands, 13th July 2022. Today IGEA Pharma N.V. (SIX: IGPH) has announced that LMH Holding has completed the due diligence process on the Com [ … ]
Technical analysis
To the publication
Wed, 13.07.2022       IGEA Pharma N.V.
NL0012768675

IGEA PHARMA HAS ANNOUNCED THAT LMH - AN INDUSTRIAL HOLDING COMPANY - HAS COMPLETED THE DUE DILIGENCE PROCESS FOR A EURO 6.000.000 COMMITTMENT TO FUND THE SWISS CBD EXTRACTION FACILITY .   Hoofddorp, the Netherlands, 13th July 2022. Today IGEA Pharma N.V. (SIX: IGPH) has announced that LMH Holding has completed the due diligence process on the Com [ … ]
Technical analysis
To the publication
Wed, 15.06.2022       IGEA Pharma N.V.
NL0012768675

  IGEA to get SIX further approval to the 2021 annual report disclosure   Hoofddorp, the Netherlands, 15 June 2022. IGEA Pharma N.V. (SIX: IGPH) today announced the grant of a temporary exemption from its disclosure obligations with respect to the 2021 annual report.   Further to the issuance of the new consolidated financial statements draft, [ … ]
Technical analysis
To the publication

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

Legend/Explanation
The newswire feed is updated several times a day. To make sure you don't miss any news, please check back here often. If you are curious about a headline or want to find out more about a publication, click on it to go to the preview and click again to go to the full news item.
Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Saturday, 21.09.2024, Calendar Week 38, 265th day of the year, 101 days remaining until EoY.